Dr. Viscomi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Carna Health
200 Newbury Street, Suite 401
Boston, MA 02116
Summary
- Dr. Salvatore Viscomi is the co-founder and CEO of Carna Health, a digital health company focused on chronic diseases. He practiced as a radiologist in Boston, MA and is affiliated with multiple hospitals in the area, including Brigham and Women's Hospital and Baystate Medical Center. He completed his residency at Harvard Medical School and has been in practice 18 years. He is on the board of Make-A-Wish.
Education & Training
Brigham and Women's Hospital/Harvard Medical SchoolResidency, Radiology-Diagnostic, 2000 - 2004
Albert Einstein Medical CenterInternship, Transitional Year, 1999 - 2000
Rutgers Robert Wood Johnson Medical SchoolClass of 1999
Certifications & Licensure
NH State Medical License 2005 - Present
CT State Medical License 2019 - 2025
MA State Medical License 2004 - 2025
RI State Medical License 2005 - 2006
Publications & Presentations
PubMed
- 41 citationsCT angiography for acute gastrointestinal bleeding: what the radiologist needs to knowJeremy R. Wortman, Wendy B. Landman, Urvi P Fulwadhva, Salvatore Viscomi, Aaron D. Sodickson
The British Journal of Radiology. 2017-04-26 - 8 citationsPeriaortic lymphoma as a mimic of posttraumatic intramural hematomaMichael T. Lu, John Millstine, Matthew T. Menard, Frank J. Rybicki, Salvatore Viscomi
Emergency Radiology. 2006-08-04 - 5 citationsQuantification of clinical consultations in academic emergency radiology1Salvatore Viscomi, Kirstin M. Shu, Elise M. Blinder, John D. MacKenzie, Stephen Ledbetter
Academic Radiology. 2004-11-01
Press Mentions
Carna Health Announces Promising Results from Cameroon Pilot Program Aimed at Slowing Progression of Chronic Kidney DiseaseAugust 15th, 2024- What’s Holding Cell Therapies Back? A Look into the Evolution and Future of Stem Cell TechJanuary 31st, 2023
- Goodcell Introduces Personalized Biobanking, Paving the Way for the Ultimate, Seamless Experience for Personalized Cell TherapiesJune 6th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
